Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Canton Strategic Holdings, Inc.

Company price
1.435 USD -0.20 ( 12.50%)
Last update at 2026-11-17T18:05:00Z
VOLUME
622867
Market Cap
162.95M

Momentum Score

…

Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management. It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.42
Low
1.67
High
52 Week Price Range
1.75
Low
5.83
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for Canton Strategic Holdings, Inc. (NASDAQ: CNTN) are limited; the company provides little detail about operations or revenue sources. Long-term growth drivers are not clearly articulated and would likely depend on execution of any stated investment strategy and underlying asset performance, which investors should monitor. Some investors may find exposure to its strategic initiatives attractive despite information gaps.

Material risks include limited transparency and disclosure, thin trading liquidity, governance and execution risk, and possible information gaps that could affect investor assessment.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.64
Dividend Yield
-
Revenue TTM
1.50M
Revenue Per Share
0.02
Gross Profit TTM
1.50M
Debt / Equity
-0.46
ROE
-42.21%
Net Debt
-17.03M
ROCE
-3.90%
Diluted EPS TTM
-0.15

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -42.10M -12.20M -9.32M -8.47M -2.21M
Net income -35.92M -12.20M -9.32M -8.47M -2.21M
Selling general administrative 17.03M 6.04M 5.90M 4.60M 1.37M
Ebit - -12.21M -9.30M -6.88M -
Ebitda -20.11M -12.43M -9.15M -6.65M -1.38M
Depreciation and amortization - -0.22M 0.15M 0.23M -
Operating income -20.11M -12.43M -9.46M -6.88M -3.21M
Other operating expenses 20.11M 12.43M 9.46M 6.88M 3.21M
Interest expense 0.03M 0.01M 0.02M 1.59M 0.83M
Tax provision -6.19M 0.00M - - -
Interest income 0.04M 0.25M 0.15M 0.00M -
Net interest income 0.01M 0.24M 0.14M -1.59M -0.83M
Income tax expense -6.19M - - - -
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 20.11M 12.43M 9.46M 6.88M 3.21M
Total other income expense net -22.00M 0.24M 0.14M -1.59M 1.00M
Net income from continuing ops -35.92M -12.20M -9.32M -8.47M -2.21M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 519.15M 3.72M 10.95M 6.69M 0.62M
Intangible assets 501.76M - - - -
Other current assets 0.35M 0.16M 0.01M 0.18M 0.62M
Total liab 121.22M 2.41M 1.82M 1.14M 5.31M
Total stockholder equity 397.93M 1.31M 9.13M 5.54M -4.68M
Other current liab 2.20M 1.32M 0.91M 0.19M 1.68M
Common stock 0.00M 0.00M 0.00M 0.00M 0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -72.82M -36.90M -24.70M -15.38M -6.91M
Cash 17.03M 3.56M 10.94M 6.51M 0.00M
Total current liabilities 3.29M 2.41M 1.82M 1.14M 4.53M
Net debt -17.03M -3.56M -10.94M -6.51M 2.16M
Short term debt - - - - 1.39M
Short long term debt - - - - 1.39M
Short long term debt total - - - - 2.17M
Other stockholder equity 470.74M 38.21M 33.83M 20.93M 2.23M
Total current assets 17.39M 3.72M 10.95M 6.69M 0.62M
Long term debt - - - - 0.77M
Accounts payable 1.09M 1.09M 0.91M 0.95M 1.46M
Non currrent assets other 501.76M 0.12M - - 0.55M
Non current assets total 501.76M 0.12M 0.00M 0.00M 0.55M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total cashflows from investing activities -77.57M - - - -
Net borrowings -0.22M 0.00M 0.00M -0.01M 1.08M
Total cash from financing activities 107.17M 3.53M 11.72M 13.06M 0.90M
Net income -35.92M -12.20M -9.32M -8.47M -2.21M
Change in cash 13.47M -7.38M 4.42M 6.51M -0.19M
Begin period cash flow 3.56M 10.94M 6.51M 0.00M 0.19M
End period cash flow 17.03M 3.56M 10.94M 6.51M 0.00M
Total cash from operating activities -16.13M -10.90M -7.30M -6.56M -1.09M
Issuance of capital stock 115.67M 4.19M 12.23M 13.65M 0.00M
Depreciation 0.02M - - - -
Other cashflows from investing activities -77.57M - - - -
Sale purchase of stock - - 0.00M -0.07M 0.00M
Other cashflows from financing activities 107.17M -0.66M -0.51M -0.50M -0.18M
Capital expenditures 77.57M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.99M 0.56M 0.84M -0.57M 1.05M
Stock based compensation 2.88M 0.71M 0.83M 0.80M 1.24M
Other non cash items 23.07M 0.02M 0.35M 1.68M -1.17M
Free cash flow -16.13M -10.90M -7.30M -6.56M -1.09M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CNTN
Canton Strategic Holdings, Inc.
-0.20
12.50%
1.44 - - 108.93 0.37 107.15 -6.32
NVO
Novo Nordisk A/S
-0.80
1.91%
40.80 41.58 31.15 2.13 32.99 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc
-2.08
0.39%
535.71 30.22 24.27 10.36 6.50 9.99 24.66
REGN
Regeneron Pharmaceuticals Inc
9.09
0.95%
961.49 29.07 20.12 7.57 3.82 6.95 19.42
ARGNF
argenx SE
-
-%
965.00 45.77 31.25 13.84 7.12 11.38 36.06

Profile*

Canton Strategic Holdings, Inc.

Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management. It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.

34 Shrewsbury Avenue, Red Bank, NJ, United States, 07701

732 889 3111

12

Name Title Year Born
Mr. Mark Wendland CEO & Chairman of the Board 1979
Mr. Mark Toomey President 1971
Mr. Jacob Asbury Chief Financial Officer 1974
Ms. Angela Dominy Radkowski Chief Operating Officer 1989

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…